PROTOKINETIX, INCORPORATED

PKTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $0 $0 $0 $0
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $337.1K $296.5K $450.9K $158.9K $13.8K $74.5K $0 $117.4K
SG&A Expense $78.1K $105.3K $99.6K $126.8K $141.5K $95.8K $119.4K $201.0K
Operating Income $-422.2K $-197.1K $-916.9K
Operating Margin
Interest Expense $306 $1.7K $12 $4.0K $34.4K $26.4K $24.0K $12.0K
Pretax Income $-448.6K $-197.1K $-1.2M
Income Tax Expense $0
Net Income $-1.2M $-1.5M $-1.5M $-1.3M $-168.5K $-448.6K $-197.1K $-1.2M
Net Margin
EPS (Basic) $0.00 $-0.01 $-0.01 $-0.01 $0.00 $0.00 $0.00 $-0.01
EPS (Diluted) $0.00 $-0.01 $-0.01 $-0.01 $0.00 $0.00 $0.00 $-0.01
Shares Outstanding (Basic)
Shares Outstanding (Diluted) 256.2M 246.6M 221.6M 198.0M 172.4M 137.1M 129.2M 93.6M
Dividends Per Share
← Newer Page 2 of 4 Older →